Competition for Herceptin biosimilar heats up in Europe

European Medicines Agency (EMA) has recommended approval to Pfizers Trastuzumab biosimilar. Biocon/Mylan have also awaiting approval on Herceptin biosimilar in EU.

from India Infoline News Service https://ift.tt/2HukiLI

Comments

Popular posts from this blog

What are the key measures of market volatility?

https://ift.tt/2IVHF6y